Table 1.
Age, Race, Ethnicity, and Medication Data, by Group, and for the Sample as a Whole
| Age | CPZ | % White | %* Hispanic | % Male | |
|---|---|---|---|---|---|
| Control (n=37) | 32.22 (12.63)† | 65 | 14 | 65 | |
|
Schizophrenia (n=28) |
32.21 (11.27)‡ | 235.58 (266.14) | 23 | 18 | 86 |
|
Total (n=65) |
32.22 (11.97) | 48 | 15 | 74 |
*Notes: Hispanic ethnicity, as reported here, is independent of race, as per NIH (USA) reporting guidelines. †The age range for younger controls was 20–27 (mean=23.05, SD=2.35), and for older controls was 30–65 (mean=41.89, SD=11.79). ‡The age range for first episode schizophrenia patients was 19–42 (mean=24.00, SD=6.22) and for later episode patients was 25–59 (mean=38.37, SD=10.28).